🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial tests the safety, side effects, and best dose of combina...
Status
Recruiting
Location
Los Angeles General Medical Center
Start Date
2024-02-06
Trial ID
NCT05711615
This phase I trial tests the safety, side effects, best dose of MUC1-activa...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2024-09-20
Trial ID
NCT06483048
Between 10% and 15% of patients with endogenous hypercortisolism (Cushing s...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2014-02-12
Trial ID
NCT02019706
Treatments Being Tested
This clinical trial aims to investigate the value of fibroblast activation ...
Status
Completed
Location
FirstHAnhuiMU
Start Date
2022-04-28
Trial ID
NCT06270394
Treatments Being Tested
This phase III trial compares the effect of bevacizumab and osimertinib com...
Status
Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2020-12-28
Trial ID
NCT04181060
This phase I trial studies the side effects and best dose of lenalidomide w...
Status
Recruiting
Location
Emory University Hospital Midtown
Start Date
2021-08-31
Trial ID
NCT04301076
This phase II trial studies how well olaparib and cediranib maleate work in...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2016-05-23
Trial ID
NCT02345265
This phase I trial tests the safety and side effects of B-cell activating f...
Status
Not Yet Recruiting
Location
City of Hope Medical Center
Start Date
2027-04-17
Trial ID
NCT07758673
Treatments Being Tested
This phase I/II tests the safety, side effects, best dose and how well givi...
Status
Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2025-11-12
Trial ID
NCT07150806
Treatments Being Tested
This phase III trial studies olaparib or cediranib maleate and olaparib to ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2016-03-28
Trial ID
NCT02446600
Treatments Being Tested